Oct 6 (Reuters) - Goldman Sachs Group Inc ( GS ):
* MAPLIGHT THERAPEUTICS INC - INITIAL PUBLIC OFFERING PRICE
IS
$17.00 PER SHARE
* MAPLIGHT THERAPEUTICS INC SEES IPO OF 14.75 MILLION SHARES
OF
COMMON STOCK - SEC FILING
* MAPLIGHT THERAPEUTICS - AFFILIATES OF GOLDMAN SACHS & CO.
LLC
ARE EXPECTED TO PURCHASE 476,707 SHARES OF COMMON STOCK IN
CONCURRENT PRIVATE PLACEMENT
* MAPLIGHT THERAPEUTICS - ACCOUNTS ADVISED BY T. ROWE PRICE
INVESTMENT MANAGEMENT INDICATED INTEREST IN PURCHASING UP TO $40
MILLION IN SHARES AT IPO PRICE
Source text:
Further company coverage: